Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Abacavir/Dolutegravir/Lamivudine in Human Immunodeficiency Virus-1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
Completed · Phase 3 · Has a placebo group
Conditions studied: HIV-1 Infection
In brief
The primary objective of this study is to evaluate the efficacy of a fixed dose combination (FDC) containing bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) versus a FDC containing abacavir/dolutegravir/lamivudine (ABC/DTG/3TC) in HIV-1 infected, antiretroviral treatment naive-adults.
Key facts
- Study ID
- NCT02607930
- Run by
- Gilead Sciences
- People needed
- 631
- Starts
- 2015-11-13
- Expected to finish
- 2021-07-02
- Last updated by the study team
- 2022-03-02
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Spectrum Medical Group — Phoenix, Arizona, United States
- Pueblo Family Physicians — Phoenix, Arizona, United States
- Kaiser Permanente Medical Center — Los Angeles, California, United States
- Ruane Clinical Research Group, Inc. — Los Angeles, California, United States
- Anthony Martin Mills MD A Medical Corporation, DBA Mills Clinical Research — Los Angeles, California, United States
- Alameda Health System- Highland Hospital — Oakland, California, United States
- University of California Davis — Sacramento, California, United States
- Kaiser Permanente Medical Group — Sacramento, California, United States
- La Playa Medical Group — San Diego, California, United States
- Kaiser Permanente — San Francisco, California, United States
- Kaiser Permanente — San Leandro, California, United States
- The Lundquist Institute for BioMedical Innovation at Harbor-UCLA Medical Center — Torrance, California, United States
- Apex Research — Denver, Colorado, United States
- Whitman-Walker Institute — Washington D.C., District of Columbia, United States
- Providence Hospital - DC — Washington D.C., District of Columbia, United States
- Capital Medical Associates — Washington D.C., District of Columbia, United States
- Medical Faculty Associates — Washington D.C., District of Columbia, United States
- Therafirst Medical Center — Fort Lauderdale, Florida, United States
- Gary J. Richmond, M.D., P.A. — Fort Lauderdale, Florida, United States
- Midway Immunology and Research Center — Ft. Pierce, Florida, United States
- AHF Kinder Medical Group — Miami, Florida, United States
- Study site — Miami, Florida, United States
- Orlando Immunology Center — Orlando, Florida, United States
- AIDS Healthcare Foundation-Miami Beach — Pensacola, Florida, United States
- University of Alabama at Birmingham — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.